What to Do, Where to Go and Why for Newly Funded University-Based New Medical Technologies

You’re a university-based researcher, investigator, faculty member or perhaps even a student who has snagged your first funding for the earliest stage commercialization, design and development activities for your potential medical technology. You might even have completed the first activities with that funding and scored $100,000 or more in follow-on funding from GRA, SBIR, or…

The GCMI 2023 State of Medtech Design and Development Report: Part 1

Innovation in medical technologies is something of a paradox. On one hand, new technologies that drive innovation can manifest at breakneck speed. On the other hand, the pace at which those technologies breed innovations that reach full commercialization and patient impact can be glacial by comparison.   What have been the most significant changes with…

GCMI CEO Sherry Farrugia Named to Inaugural Atlanta Business Chronicle “Power 10 in Health Care”

GCMI team members continue to distinguish themselves through industry association or other external recognition. Very recently this was the case for our CEO Sherry Farrugia who was named to the inaugural Atlanta Business Chronicle “Power 10: Health Care list.”   From the publication: “​​There is no shortage of exceptional health care professionals in metro Atlanta.…

What do pediatric innovators need to know about risk, regulatory, IP and more for new pediatric technologies? A Pediatric Tech Talk recording.

Innovation in pediatric technologies that address unmet clinical needs lags behind innovation for adult populations in large part due to its relatively small market size and ROI (return on investment) prospects for industry, continuously changing anatomies of children, and limited populations for testing and clinical trials.   Activity sequence and process matters a great deal…

The Top Five Medtech and Life Science Funding Sources for GT Faculty, Researchers, Investigators – AT PHASE ZERO

Atlanta is a burgeoning center of medtech and life science innovation. Georgia Tech faculty, researchers and students are measurable contributors to that ecosystem.   Medtech innovation and the commercialization that creates real impact in provision of care, improved outcomes and value is replete with requirements and pitfalls that can doom ideas and technologies with high…

It’s About Time! 2023 BME Spring Capstone Team Aims to Reduce 70% Failure Rate of Common Lumbar Punctures

Lumbar punctures are a procedure performed by neurologists to obtain cerebrospinal fluid from a patient’s back, typically from the L3/L4 spinal canal, and are used for diagnosis and treatment of many neurological diseases and cancers. There are more than 8 million conducted worldwide every year, including 370,000 in the United States.   Currently, doctors feel…

Consolidation, Planning and Due Diligence: Our Annual Spotlight on the State of Preclinical for 2023

GCMI and our preclinical arm also known as T3 Labs is a trusted, proven industry-leading preclinical CRO for medical devices and other medical products. We’re an AAALAC accredited facility that conducts feasibility, proof of concept, feasibility, and safety and efficacy GLP medical device testing for studies in any therapeutic area and in small and large…

Reducing the 90% Recurrence Rate for Glioblastoma Treatment Through an Implantable Device for the Delivery of Stem Cells

GCMI’s Spring 2023 Capstone Spotlight on Team LifeSTEM “Gliomas are brain tumors that come in multiple forms ranging from low-grade, benign tumors to high-grade, malignant tumors including glioblastomas. Glioblastoma treatment involves surgical resection, chemotherapy, and radiation. However, these tumors are typically incompletely resected, so there is a 90% recurrence rate [for a course of treatment,…